FDA Clears Clobazam Oral Film (Sympazan) for Lennox-Gastaut

The FDA has approved an oral film formulation of clobazam for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients aged 2 years and older.
FDA Approvals

Source link

Related posts

Migraine Matters


HealthGrades Review


Teaching NeuroImages: X-linked adrenoleukodystrophy: Spinocerebellar variant


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World